Proteomics strategies for target identification and biomarker discovery in cancer

Keyphrases

• Antiangiogenic Therapy 33%
• Biofluids 66%
• Biological Markers 33%
• Biomarker Discovery 100%
• Cellular Process 33%
• Cerebrospinal Fluid 33%
• Complex Technology 33%
• Diagnostic Test 33%
• Fluid Identification 33%
• Fractionation Process 33%
• In Cancer 100%
• Label-free Method 33%
• Liquid Chromatography 33%
• Mass Spectrometry 66%
• Oncology 33%
• Oncoproteomics 33%
• Protein Labeling 33%
• Protein Separation 33%
• Protein-peptide Complex 66%
• Proteome 33%
• Proteomic Strategy 100%
• Proteomics 66%
• Proteomics Methods 33%
• Quantitative Methods 33%
• Sample Complexity 33%
• Secretome 33%
• Separation Techniques 33%
• Solid Tumors 33%
• Stable Isotope Labeling 33%
• Tandem Mass Spectrometry 33%
• Target Biomarker 100%
• Target Identification 100%
• Technology Support 33%
• Therapeutic Target 33%
• Tumor Marker 33%

Biochemistry, Genetics and Molecular Biology

• Biomarker Discovery 100%
• Blood Plasma 25%
• Chromatography 25%
• Fractionation 25%
• Genomics 25%
• Isotope Labeling 25%
• Mass Spectrometry 50%
• Peptide 50%
• Proteome 25%
• Proteomics 100%
• Quantitative Technique 25%
• Secretome 25%
• Separation Method 25%
• Tandem Mass Spectrometry 25%
• Tumor Marker 25%

Chemistry

• Antiangiogenic 25%
• Biological Marker 100%
• Fractionation 25%
• Liquid Chromatography 25%
• Mass Spectrometry 50%
• Peptide 50%
• Proteomics 100%
• Stable Isotope 25%
• Tandem Mass Spectrometry 25%
• Target Identification 100%
• Tumor Marker 25%